Announcements Trials

Browse Landscape

Phase

Phase 1 8 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 238 Carcinoma, Non-Small-Cell Lung 205 Prostatic Neoplasms 137 Lung Neoplasms 96 Stomach Neoplasms 85 Head and Neck Neoplasms 58 Squamous Cell Carcinoma of Head and Neck 57 Neoplasms 42 Neoplasm Metastasis 39 Esophageal Neoplasms 36 Ovarian Neoplasms 29 Pancreatic Neoplasms 27 Sarcoma 19 Urinary Bladder Neoplasms 18 Adenocarcinoma of Lung 18 Carcinoma, Squamous Cell 17 Triple Negative Breast Neoplasms 15 Nasopharyngeal Carcinoma 14 Adenocarcinoma 14 Carcinoma, Ovarian Epithelial 13 Adenocarcinoma Of Esophagus 13 Recurrence 12 Inflammatory Breast Neoplasms 10 Carcinoma, Transitional Cell 10 Breast Neoplasms, Male 10 Esophageal Squamous Cell Carcinoma 9 Laryngeal Neoplasms 8 Uterine Cervical Neoplasms 7 Nasopharyngeal Neoplasms 7 Leiomyosarcoma 7

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 toripalimab 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 seviteronel 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Docetaxel × Clear all

NCT04827576 2025-05-08

ELEVATELung&UC

Gilead Sciences

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡